Kynam Capital Management, LP
Position in VRDN — Viridian Therapeutics, Inc.\DE
CIK 1907884
PRINCETON, NJ
Position in VRDN
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$45,802,713
+$39,478 QoQ
Shares Held
2,341,652
+59.2% QoQ
Ownership
2.27%
of shares outstanding
% of Portfolio
2.91%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2021
18 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VRDN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Kynam Capital Management, LP holds $1,494,846,229 across 33 Biotechnology names. VRDN ranks #9 (3.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | SNDX |
Syndax Pharmaceuticals Inc
|
8,050,959 | $188,070,402 | |
| 2 | CLDX |
Celldex Therapeutics, Inc.
|
5,840,567 | $185,262,785 | |
| 3 | PCVX |
Vaxcyte, Inc.
|
2,922,335 | $169,816,886 | |
| 4 | COGT |
Cogent Biosciences, Inc.
|
4,037,331 | $155,396,870 | |
| 5 | VERA |
Vera Therapeutics, Inc.
|
3,398,224 | $136,710,551 | |
| 6 | BEAM |
Beam Therapeutics Inc.
|
3,682,185 | $87,746,468 | |
| 7 | CTMX |
CytomX Therapeutics, Inc.
|
15,013,093 | $70,561,537 | |
| 8 | TVTX |
Travere Therapeutics, Inc.
|
1,569,018 | $46,615,524 |
All Filings in VRDN
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $45,802,713 | 2,341,652 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $45,763,235 | 1,470,541 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $95,554,664 | 4,427,927 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $61,902,419 | 4,427,927 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $63,356,000 | 4,700,000 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $63,764,442 | 3,326,262 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $57,131,961 | 2,511,295 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $22,767,500 | 1,750,000 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $2,344,186 | 133,877 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $13,240,388 | 607,915 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $10,733,106 | 699,681 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $16,878,957 | 709,498 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $13,829,260 | 543,603 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $30,223,499 | 1,034,697 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $20,510,000 | 1,000,000 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $6,827,954 | 590,143 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $10,905,882 | 589,826 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $5,692,455 | 287,934 | Shares | Sole | 2022-02-14 | |
| No filing history on record for this holder in this stock. | ||||||